Загрузка...
A Randomized, Phase I Pharmacokinetic Study Comparing SB2 and Infliximab Reference Product (Remicade(®)) in Healthy Subjects
OBJECTIVE: SB2, a biosimilar to infliximab reference product (INF), has an identical amino acid sequence and similar physicochemical functional properties to its reference product. The primary objective of this study is to demonstrate pharmacokinetic (PK) bioequivalence between SB2 and EU-sourced IN...
Сохранить в:
| Опубликовано в: : | BioDrugs |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer International Publishing
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4684585/ https://ncbi.nlm.nih.gov/pubmed/26577771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-015-0150-5 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|